"First, as patients were being treated with IVM in Sydney and Melbourne with the impressive results mentioned above, the Therapeutic Goods Administration (TGA) made an extraordinary move to shut down the prescribing of IVM by frontline doctors for the treatment and prevention of Covid-19. The TGA has form, as it made a similar ruling on hydroxychloroquine (HCQ), the other re-purposed off-patent drug shown to be effective in treating Covid-19. Importantly, the reasons given by the TGA to justify its decision were not correct."

Read, listen or watch here at quadrant.org

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>